Chardan Capital Reiterates “Buy” Rating for Ocugen (NASDAQ:OCGN)
Ocugen (NASDAQ:OCGN – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Chardan Capital in a research note issued on Monday,Benzinga reports. They currently have a $6.00 price objective on the stock. Other research analysts also recently issued research reports about the company. Maxim Group assumed coverage on Ocugen in a […]
More Stories
Ukraine Launches Drone Strikes on Air Bases Deep Inside Russia
By Jacob Burg Ukraine launched a massive drone strike on June 1, hitting multiple Russian airbases, according to the Russian...
Iran Says It Has Some Details of US Proposal for New Nuclear Deal
By Ryan Morgan Iranian Foreign Minister Abbas Araghchi has seen some of the first details of a U.S.-drafted proposal for...
Wexford Capital LP Buys New Shares in NVIDIA Co. (NASDAQ:NVDA)
Wexford Capital LP bought a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) during the 4th quarter,...
Best Streaming Stocks To Keep An Eye On – May 30th
NVIDIA, AppLovin, Spotify Technology, Live Nation Entertainment, and Walt Disney are the five Streaming stocks to watch today, according to...
Infrastructure Stocks Worth Watching – May 30th
NVIDIA, Alphabet, and Broadcom are the three Infrastructure stocks to watch today, according to MarketBeat’s stock screener tool. Infrastructure stocks...
Two Sigma Investments LP Cuts Position in Academy Sports and Outdoors, Inc. (NASDAQ:ASO)
Two Sigma Investments LP reduced its holdings in shares of Academy Sports and Outdoors, Inc. (NASDAQ:ASO – Free Report) by...